Managing Cardiac Disease and Potassium Levels with Midamor

Cardiac arrhythmia can lead to significant health complications that must be well managed to improve long term health. While there are many electrolyte complications that may arise from complications of cardiac arrhythmia, the most common is that involving abnormal potassium, sodium and magnesium levels.

If you live with a cardiovascular complication that has resulted in the development of cardiac arrhythmia, it is important to ask your physician about the use of medications as a way to promote electrolyte balance. When not effectively managed, electrolyte imbalance can lead to life threatening health complications.

For many patients with an electrolyte imbalance in connection with the cardiac arrhythmia, the use of prescription Midamor is quite common. Specifically, when your potassium levels are low, your physician may want to prescribe Midamor as part of your total cardiac treatment plan.

As a once-per-day dosing formula, in five milligram tablets, is generally all that is needed to assist in capturing control over your potassium levels and restore electrolyte balance. However, if your complications with cardiac arrhythmia are not sufficiently managed, your physician can increase your dosing to twice-per-day with as much as 10 milligrams per day in that same dosing.

As with any FDA approved drug, if you suffer from cardiac arrhythmia and utilize Midamor, you can expect there will be some side effects with use. Most common side effects experienced with Midamor include nausea, abdominal pain, gas and even the development of a rash. If you notice any of these symptoms or side effects are quite complex, be certain you consult your cardiologist before ceasing use.

For cardiac patients with a pre-existing history of liver disorder or complications of anemia, there may be some health risks associated with using Midamor in managing your cardiac arrhythmia. For this reason, be certain your physician completes a full physician to ascertain your liver panel results and blood levels before beginning treatment. For women who are pregnant, or may become pregnant, the use of Midamor is considered safe and classified as a Category B drug.

Cardiovascular complications can lead to adverse health risks. For many adults, the complications of the cardiac system involve the development of cardiac arrhythmia. To effectively manage your potassium levels, and balance electrolytes, consider using Midamor as an effective treatment option in a once-per-day dosing formula. Without proper management of potassium levels, your health risks can lead to electrolyte imbalance, edema, and ultimately increase the likelihood of an adverse health risk including death.